The Leadership Team at FogPharma is responsible for guiding the company's strategic direction and decision-making in the pursuit of developing innovative therapies for previously untargetable diseases. Comprising key executives in discovery, clinical sciences, and human resources, the team collaborates to foster a culture of scientific excellence and drive the successful advancement of cell-penetrating miniproteins through research, clinical trials, and talent development.